These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 6197167

  • 1. Serum tumor markers in metastatic breast cancer and course of disease.
    Caffier H, Brandau H.
    Cancer Detect Prev; 1983; 6(4-5):451-7. PubMed ID: 6197167
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Value of CA 125 in comparison to conventional tumor markers in ovarian cancer].
    Paulick R, Kaesemann H, Caffier H.
    Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):509-14. PubMed ID: 2875919
    [Abstract] [Full Text] [Related]

  • 5. Human tissue polypeptide antigen in breast cancer.
    Nemoto T, Constantine R, Chu TM.
    J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
    [Abstract] [Full Text] [Related]

  • 6. [The tumor markers TPA and CEA in the after care of breast cancer].
    Beaufort F, Fueger GF, Steiner H.
    Wien Med Wochenschr; 1985 Feb 28; 135(4):85-8. PubMed ID: 2986366
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. How can treatment response be measured in breast cancer patients?
    van Dalen A, van der Linde DL, Heering KJ, van Oudalblas AB.
    Anticancer Res; 1993 Feb 28; 13(5C):1901-4. PubMed ID: 8267398
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
    Björklund V, Björklund B.
    Cancer Detect Prev; 1983 Feb 28; 6(1-2):193-8. PubMed ID: 6883380
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum CEA, CA 15-3, and MCA in breast cancer patients: a clinical evaluation.
    Repetto L, Onetto M, Gardin G, Costanzi B, Giudici S, Vitiello E, Merlini L, Naso C, Zannini C, Paganuzzi M.
    Cancer Detect Prev; 1993 Feb 28; 17(3):411-5. PubMed ID: 8402728
    [Abstract] [Full Text] [Related]

  • 18. Combined use of carcinoembryonic antigen and tissue polypeptide antigen in oncologic therapy and surveillance.
    Lüthgens M, Schlegel G.
    Cancer Detect Prev; 1983 Feb 28; 6(1-2):51-9. PubMed ID: 6883393
    [Abstract] [Full Text] [Related]

  • 19. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
    Taback B, Chan AD, Kuo CT, Bostick PJ, Wang HJ, Giuliano AE, Hoon DS.
    Cancer Res; 2001 Dec 15; 61(24):8845-50. PubMed ID: 11751407
    [Abstract] [Full Text] [Related]

  • 20. Tissue polypeptide antigen and carcinoembryonic antigen in colon tumors: serum levels and immunohistochemical localization.
    Bombardieri E, Jotti GS, Cocciolo MG, Mori M, Rusconi A, Rusca M, Seregni E, Becchi G, Fontanesi M, Tardini A.
    Cancer Detect Prev; 1985 Dec 15; 8(1-2):219-26. PubMed ID: 4064041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.